Get my own profile
Public access
View all24 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Thomas TuschlThe Rockefeller UniversityVerified email at rockefeller.edu
- Thomas BrieseVerified email at columbia.edu
- Markus HafnerSenior Investigator, NIAMS, National Institutes of HealthVerified email at nih.gov
- Kathrin TyryshkinAdjunct Assistant Professor, Dept. Pathology and Molecular Medicine/School of Computing, Queen'sVerified email at queensu.ca
- Omar J JabadoPrincipal Scientist, Genmab, NJVerified email at genmab.com
- Nicole Dukers-MuijrersSenior Epidemiologist, Public Health Service South Limburg, Maastricht University CAPHRIVerified email at ggdzl.nl
- Justin WongQueen's UniversityVerified email at queensu.ca
- Jingyue JuProfessor of Chemical Engineering and Pharmacology, Columbia UniversityVerified email at columbia.edu
- Jina NanayakkaraQueen's UniversityVerified email at queensu.ca
- Theresa ScognamiglioAssistant Professor of Pathology, Weill Cornell Medical CollegeVerified email at med.cornell.edu
- Yao-Tseng ChenWeill Cornell Medical CollegeVerified email at med.cornell.edu
- David L HirschbergRAIN IncubatorVerified email at rainincubator.org
- Julie SheldonTwincoreVerified email at twincore.de
- Jonathan S. TownerViral Special Pathogens Branch, Centers for Disease Control and PreventionVerified email at cdc.gov
- pavol cekanMultiplexDXVerified email at multiplexdx.com
- Iddo Z. Ben-DovHead, Internal Medicine B, Hadassah Medical CenterVerified email at hadassah.org.il
- guy simpsonuniversity of surreyVerified email at surrey.ac.uk
- John F. CraryIcahn School of Medicine at Mount SinaiVerified email at mountsinai.org
- Ismael Santa-MariaColumbia UniversityVerified email at cumc.columbia.edu
- Thalia FaraziMedical Director, Juno Therapeutics A Celgene CompanyVerified email at junotherapeutics.com